Therapeutic failure after regimen with artemether-lumefantrine combination therapy: a report of three cases in Benin City, Nigeria
AUTOR(ES)
Ebohon, Osamudiamen
FONTE
Rev. Soc. Bras. Med. Trop.
DATA DE PUBLICAÇÃO
10/10/2019
RESUMO
Abstract Artemisinin-based combination therapy (ACT) is recommended by the World Health Organization for the treatment of uncomplicated malaria. Currently, there appears to be a downward trend in the efficacy of ACT in some parts of sub-Saharan Africa because some patients have been positive for Plasmodium parasite 3 days after artemether-lumefantrine treatment. We reported three cases of possible parasite resistance to artemether-lumefantrine therapy. All subjects had complete parasite clearance when treated with other antimalarial drugs. This observation necessitates the urgent need to re-evaluate artemether-lumefantrine medication in Nigeria since it is one of the most commonly used ACT drug.
Documentos Relacionados
- Possible artemisinin-based combination therapy-resistant malaria in Nigeria: a report of three cases
- Oral hygiene in primary schoolchildren in Benin City, Nigeria.
- Incidence of penicillinase producing Neisseria gonorrhoeae (PPNG) strains and susceptibility of gonococcal isolates to antibiotics in Benin City, Nigeria.
- Severe Rhabdomyolysis Associated with the Cerivastatin-Gemfibrozil Combination Therapy: Report of a Case
- The problem of uveitis in Bendel State of Nigeria: experience in Benin City.
